Surgical Result and Identification of FGFR2 Variants Using Whole-Exome Sequencing in a Chinese Family With Crouzon Syndrome

J Craniofac Surg. 2022 Jan-Feb;33(1):134-138. doi: 10.1097/SCS.0000000000008153.

Abstract

Crouzon syndrome is considered as one of the most common craniosynostosis syndromes with a prevalence of 1 in 65,000 individuals, and has a close relationship with variants in fibroblast growth factor receptor 2. Here the authors described a Crouzon syndrome case, which was asked for surgery treatment for the symptom of multisuture craniosynostosis. Mild midfacial retrusion, larger head circumference, proptosis, pseudo-prognathism, and dental malposition could also be found obviously. Then fronto-orbital advancement and cranial cavity expansion were performed to the child. After whole-exome sequencing (WES) and Sanger sequencing, gene variants in the exons 2 and 3 of FGFR2 were detected. And protein tyrosine 105 replaced by cysteine in the extracellular region of FGFR2 was also detected. After operation, she presented a satisfactory anterior plagiocephaly and scaphocephaly correction, and the result was satisfied by surgeons and her parents. Variants detected using WES have further research prospect.

MeSH terms

  • Child
  • China
  • Craniofacial Dysostosis* / genetics
  • Craniofacial Dysostosis* / surgery
  • Craniosynostoses* / genetics
  • Craniosynostoses* / surgery
  • Exome Sequencing
  • Female
  • Humans
  • Mutation
  • Receptor, Fibroblast Growth Factor, Type 2 / genetics

Substances

  • FGFR2 protein, human
  • Receptor, Fibroblast Growth Factor, Type 2